PCRX
Pacira BioScienc (PCRX)
NASDAQ
$25.18+$0.16 (+0.66%)
Price as of Oct 02, 2026 4:15 PM EDT
  • $996.9M
    Market Cap
  • 1.75%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 35
Valuation
PCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
0

Momentum Score

Score: 43
Valuation
PCRX
vs History
vs S&P 500
3-Month Momentum
4.34%
12-Month Momentum
4.75%
3-Month Risk Adjusted Momentum
28.55%
12-Month Risk Adjusted Momentum
13.04%

True Yield

N/A
Valuation
PCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
10.03%
Net Debt Paydown Yield
0.95%

Financial Health Score

Score: 77
Valuation
PCRX
vs History
vs S&P 500
Ohlson's O-Score
7